A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model

Laetitia Davidovic, Vincent Navratil, Carmela M. Bonaccorso, Maria Vincenza Catania, Barbara Bardoni, Arc Emmanuel Dumas

Research output: Contribution to journalArticle

Abstract

Fragile X syndrome (FXS) is the first cause of inherited intellectual disability, due to the silencing of the X-linked Fragile X Mental Retardation 1 gene encoding the RNA-binding protein FMRP. While extensive studies have focused on the cellular and molecular basis of FXS, neither human Fragile X patients nor the mouse model of FXS-the Fmr1-null mouse-have been profiled systematically at the metabolic and neurochemical level to provide a complementary perspective on the current, yet scattered, knowledge of FXS. Using proton high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR)-based metabolic profiling, we have identified a metabolic signature and biomarkers associated with FXS in various brain regions of Fmr1-deficient mice. Our study highlights for the first time that Fmr1 gene inactivation has profound, albeit coordinated consequences in brain metabolism leading to alterations in: (1) neurotransmitter levels, (2) osmoregulation, (3) energy metabolism, and (4) oxidative stress response. To functionally connect Fmr1-deficiency to its metabolic biomarkers, we derived a functional interaction network based on the existing knowledge (literature and databases) and show that the FXS metabolic response is initiated by distinct mRNAtargets and proteins interacting with FMRP, and then relayed by numerous regulatory proteins. This novel "integrated metabolome and interactome mapping" (iMIM) approach advantageously unifies novel metabolic findings with previously unrelated knowledge and highlights the contribution of novel cellular pathways to the pathophysiology of FXS. These metabolomic and integrative systems biology strategies will contribute to the development of potential drug targets and novel therapeutic interventions, which will eventually benefit FXS patients.

Original languageEnglish
Pages (from-to)2190-2202
Number of pages13
JournalGenome Research
Volume21
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Fragile X Syndrome
Metabolomics
Systems Biology
Brain
Biomarkers
Osmoregulation
RNA-Binding Proteins
Metabolome
Gene Silencing
Intellectual Disability
Energy Metabolism
Neurotransmitter Agents
Protons
Proteins
Oxidative Stress
Magnetic Resonance Spectroscopy
Databases

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model. / Davidovic, Laetitia; Navratil, Vincent; Bonaccorso, Carmela M.; Catania, Maria Vincenza; Bardoni, Barbara; Dumas, Arc Emmanuel.

In: Genome Research, Vol. 21, No. 12, 12.2011, p. 2190-2202.

Research output: Contribution to journalArticle

Davidovic, Laetitia ; Navratil, Vincent ; Bonaccorso, Carmela M. ; Catania, Maria Vincenza ; Bardoni, Barbara ; Dumas, Arc Emmanuel. / A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model. In: Genome Research. 2011 ; Vol. 21, No. 12. pp. 2190-2202.
@article{bd98a6af890f421ca8d3bcfb075d3d26,
title = "A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model",
abstract = "Fragile X syndrome (FXS) is the first cause of inherited intellectual disability, due to the silencing of the X-linked Fragile X Mental Retardation 1 gene encoding the RNA-binding protein FMRP. While extensive studies have focused on the cellular and molecular basis of FXS, neither human Fragile X patients nor the mouse model of FXS-the Fmr1-null mouse-have been profiled systematically at the metabolic and neurochemical level to provide a complementary perspective on the current, yet scattered, knowledge of FXS. Using proton high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR)-based metabolic profiling, we have identified a metabolic signature and biomarkers associated with FXS in various brain regions of Fmr1-deficient mice. Our study highlights for the first time that Fmr1 gene inactivation has profound, albeit coordinated consequences in brain metabolism leading to alterations in: (1) neurotransmitter levels, (2) osmoregulation, (3) energy metabolism, and (4) oxidative stress response. To functionally connect Fmr1-deficiency to its metabolic biomarkers, we derived a functional interaction network based on the existing knowledge (literature and databases) and show that the FXS metabolic response is initiated by distinct mRNAtargets and proteins interacting with FMRP, and then relayed by numerous regulatory proteins. This novel {"}integrated metabolome and interactome mapping{"} (iMIM) approach advantageously unifies novel metabolic findings with previously unrelated knowledge and highlights the contribution of novel cellular pathways to the pathophysiology of FXS. These metabolomic and integrative systems biology strategies will contribute to the development of potential drug targets and novel therapeutic interventions, which will eventually benefit FXS patients.",
author = "Laetitia Davidovic and Vincent Navratil and Bonaccorso, {Carmela M.} and Catania, {Maria Vincenza} and Barbara Bardoni and Dumas, {Arc Emmanuel}",
year = "2011",
month = "12",
doi = "10.1101/gr.116764.110",
language = "English",
volume = "21",
pages = "2190--2202",
journal = "Genome Research",
issn = "1088-9051",
publisher = "Cold Spring Harbor Laboratory Press",
number = "12",

}

TY - JOUR

T1 - A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model

AU - Davidovic, Laetitia

AU - Navratil, Vincent

AU - Bonaccorso, Carmela M.

AU - Catania, Maria Vincenza

AU - Bardoni, Barbara

AU - Dumas, Arc Emmanuel

PY - 2011/12

Y1 - 2011/12

N2 - Fragile X syndrome (FXS) is the first cause of inherited intellectual disability, due to the silencing of the X-linked Fragile X Mental Retardation 1 gene encoding the RNA-binding protein FMRP. While extensive studies have focused on the cellular and molecular basis of FXS, neither human Fragile X patients nor the mouse model of FXS-the Fmr1-null mouse-have been profiled systematically at the metabolic and neurochemical level to provide a complementary perspective on the current, yet scattered, knowledge of FXS. Using proton high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR)-based metabolic profiling, we have identified a metabolic signature and biomarkers associated with FXS in various brain regions of Fmr1-deficient mice. Our study highlights for the first time that Fmr1 gene inactivation has profound, albeit coordinated consequences in brain metabolism leading to alterations in: (1) neurotransmitter levels, (2) osmoregulation, (3) energy metabolism, and (4) oxidative stress response. To functionally connect Fmr1-deficiency to its metabolic biomarkers, we derived a functional interaction network based on the existing knowledge (literature and databases) and show that the FXS metabolic response is initiated by distinct mRNAtargets and proteins interacting with FMRP, and then relayed by numerous regulatory proteins. This novel "integrated metabolome and interactome mapping" (iMIM) approach advantageously unifies novel metabolic findings with previously unrelated knowledge and highlights the contribution of novel cellular pathways to the pathophysiology of FXS. These metabolomic and integrative systems biology strategies will contribute to the development of potential drug targets and novel therapeutic interventions, which will eventually benefit FXS patients.

AB - Fragile X syndrome (FXS) is the first cause of inherited intellectual disability, due to the silencing of the X-linked Fragile X Mental Retardation 1 gene encoding the RNA-binding protein FMRP. While extensive studies have focused on the cellular and molecular basis of FXS, neither human Fragile X patients nor the mouse model of FXS-the Fmr1-null mouse-have been profiled systematically at the metabolic and neurochemical level to provide a complementary perspective on the current, yet scattered, knowledge of FXS. Using proton high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR)-based metabolic profiling, we have identified a metabolic signature and biomarkers associated with FXS in various brain regions of Fmr1-deficient mice. Our study highlights for the first time that Fmr1 gene inactivation has profound, albeit coordinated consequences in brain metabolism leading to alterations in: (1) neurotransmitter levels, (2) osmoregulation, (3) energy metabolism, and (4) oxidative stress response. To functionally connect Fmr1-deficiency to its metabolic biomarkers, we derived a functional interaction network based on the existing knowledge (literature and databases) and show that the FXS metabolic response is initiated by distinct mRNAtargets and proteins interacting with FMRP, and then relayed by numerous regulatory proteins. This novel "integrated metabolome and interactome mapping" (iMIM) approach advantageously unifies novel metabolic findings with previously unrelated knowledge and highlights the contribution of novel cellular pathways to the pathophysiology of FXS. These metabolomic and integrative systems biology strategies will contribute to the development of potential drug targets and novel therapeutic interventions, which will eventually benefit FXS patients.

UR - http://www.scopus.com/inward/record.url?scp=83055168319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83055168319&partnerID=8YFLogxK

U2 - 10.1101/gr.116764.110

DO - 10.1101/gr.116764.110

M3 - Article

C2 - 21900387

AN - SCOPUS:83055168319

VL - 21

SP - 2190

EP - 2202

JO - Genome Research

JF - Genome Research

SN - 1088-9051

IS - 12

ER -